橡楚编辑部 8/27/2026 47 min read
This article analyzes the core characteristics of medical grade LSR silicone in detail, including core advantages such as biocompatibility, sterilization resistance, and safety stability. It sorts out the application standards in scenarios such as medical catheters, implantable devices, and medical protective accessories, and introduces the key points of quality control in the molding process of medical grade LSR, providing professional reference for material selection and process optimization of medical consumable manufacturers.
Liquid Silicone Rubber (LSR) is a two-part, platinum-cured elastomer that has emerged as a critical material for medical device manufacturing over the past two decades. Unlike traditional high-consistency rubber (HCR) or thermoplastic elastomers (TPEs), medical grade LSR silicone undergoes strict purification and validation processes to meet global regulatory requirements for biocompatibility, chemical resistance, and long-term performance in clinical settings. Its unique combination of mechanical stability, low cytotoxicity, and compatibility with high-volume injection molding makes it suitable for applications ranging from short-term diagnostic tools to long-term implantable devices. This article provides a technical deep dive into the core performance advantages of medical grade LSR, standardized manufacturing and processing specifications, clinical use case requirements, and regulatory compliance frameworks to guide material selection and product development for medical device OEMs.
The clinical suitability of medical grade LSR stems from its tailored molecular structure, which consists of a backbone of alternating silicon and oxygen atoms with methyl or functional side groups, cured via platinum-catalyzed addition reaction to minimize residual impurities. This section outlines the key performance metrics that distinguish medical grade LSR from non-medical silicone variants and competing elastomer materials.
Biological safety is the foundational requirement for medical materials, and medical grade LSR is engineered to meet the most stringent global biocompatibility standards for all contact durations. Unlike peroxide-cured silicones, which leave residual byproducts such as dicumyl peroxide and volatile organic compounds (VOCs) that can trigger inflammatory responses, platinum-cured medical grade LSR has zero residual curing agents after post-curing, with extractable and leachable (E&L) levels well below regulatory thresholds.
Table 1: Biocompatibility Test Performance of Standard Medical Grade LSR
For long-term implantable applications (contact duration > 30 days), high-purity medical grade LSR formulations also pass ISO 10993-6 subchronic toxicity testing and ISO 10993-7 ethylene oxide (EtO) sterilization residue testing, with no observed fibrous capsule formation after 90 days of subcutaneous implantation in rabbit models, a key advantage over TPEs which often trigger mild chronic inflammation in long-term contact scenarios.
Medical grade LSR maintains consistent performance across the extreme conditions common in clinical use, including repeated sterilization cycles, exposure to bodily fluids and pharmaceutical agents, and cyclic mechanical loading. Its glass transition temperature (Tg) of -120°C to -50°C ensures flexibility even in cryogenic storage environments, while thermal degradation does not occur below 280°C, making it compatible with all standard medical sterilization methods.
Table 2: Mechanical and Thermal Performance Parameters of Typical Medical Grade LSR Formulations (40 Shore A Hardness)
Chemical resistance is another critical performance attribute: medical grade LSR is inert to most bodily fluids (blood, saliva, gastric acid, urine), common disinfectants (isopropyl alcohol, hydrogen peroxide, quaternary ammonium compounds), and many pharmaceutical active ingredients (APIs). It exhibits <0.1% mass change after 30 days of immersion in pH 1.2 gastric fluid simulants, and no measurable API adsorption for most small-molecule drugs, eliminating the risk of dose alteration for drug delivery components. Unlike polyvinyl chloride (PVC), medical grade LSR does not require plasticizers such as phthalates, which are known endocrine disruptors, making it safer for pediatric and prenatal care applications.
Medical grade LSR’s low viscosity (10,000 – 1,000,000 cP before curing, adjustable via formulation) enables high-precision injection molding with shot weights as low as 0.005 g, making it suitable for micro-components such as catheter balloons, microneedle arrays, and implantable sensor seals. Its fast curing kinetics (10 – 30 seconds at 150°C, depending on part thickness) supports high-volume production with cycle times 30 – 50% shorter than HCR compression molding, reducing per-unit costs for disposable devices.
Key design advantages unique to medical grade LSR include:
The performance of medical grade LSR components is highly dependent on controlled processing conditions that avoid contamination, ensure consistent curing, and minimize residual impurities. This section outlines standardized processing requirements for medical device production.
Medical grade LSR is supplied as two-part kits (Part A: base polymer + platinum catalyst; Part B: crosslinker + inhibitor) that require strict handling to prevent cross-contamination and premature curing. All raw material batches must come with a Certificate of Analysis (CoA) confirming biocompatibility test results, residual heavy metal levels (total heavy metals ≤ 10 ppm, arsenic ≤ 2 ppm, lead ≤ 3 ppm), and lot-to-lot consistency of viscosity and curing kinetics.
Storage requirements for unopened medical grade LSR kits include:
For opened kits, unused material must be sealed under nitrogen atmosphere to prevent moisture absorption, and used within 72 hours of opening to avoid contamination from airborne particulates. All material transfer equipment (pumps, hoses, mixing nozzles) must be dedicated to medical grade LSR and cleaned with isopropyl alcohol between production runs to eliminate cross-contamination with non-medical materials.
LSR injection molding for medical applications requires closed-loop process monitoring to ensure part consistency and compliance with ISO 13485 quality management system requirements. The two-part LSR is first mixed at a precise 1:1 ratio via a static mixer, with in-line viscosity monitoring to detect any batch-to-batch variation or material degradation before injection.
Table 3: Standard Injection Molding Process Parameters for 40 Shore A Medical Grade LSR
Critical in-process quality checks for medical LSR molding include:
Even after molding, medical grade LSR components require post-processing steps to remove residual impurities and validate performance for clinical use. The primary post-processing step is post-curing, which involves heating parts at 150 – 200°C for 2 – 4 hours under a nitrogen atmosphere to eliminate residual unreacted oligomers, crosslinker fragments, and volatile organic compounds (VOCs). Proper post-curing reduces total extractable levels by 70 – 90% compared to as-molded parts, with VOC levels reduced to <0.1% of total part weight, meeting ISO 10993-17 limits for leachable substances.
Additional post-processing steps for specific applications include:
All post-processed parts must undergo lot-level validation including:
Medical grade LSR is used across three broad categories of medical devices, each with unique performance requirements and testing protocols. This section outlines tailored specifications for the most common use cases.
Disposable devices with skin, mucosal, or short-term tissue contact (≤ 24 hours) account for 60% of medical grade LSR usage, driven by low material cost, high production throughput, and minimal risk of adverse patient reactions. Common applications include syringe stoppers, infusion set seals, surgical mask nose bridges, wound dressing contact layers, and diagnostic electrode pads.
Key specifications for disposable LSR devices include:
For diagnostic devices such as glucose test strip sensors and nucleic acid test cartridges, medical grade LSR’s low protein adsorption (≤ 5 ng/cm² for bovine serum albumin) prevents interference with assay reagents, improving test accuracy by reducing false negative rates by up to 3% compared to TPE seals.
Non-implanted devices with extended contact duration (24 hours to 30 days for semi-permanent, > 30 days for long-term) include catheter components, ostomy seals, respiratory mask cushions, and enteral feeding tube components. These applications require enhanced resistance to bodily fluid exposure, repeated flexing, and long-term biocompatibility.
Key specifications for these devices include:
For blood-contacting devices such as catheter lumens and dialysis machine seals, specialized hemocompatible medical grade LSR formulations meet ISO 10993-4 requirements, with hemolysis rate ≤ 1% and platelet adhesion ≤ 10 platelets/μm², reducing the risk of thrombus formation during extended use.
Implantable LSR devices, including pacemaker leads, cochlear implant seals, breast implant shells, and glaucoma drainage shunts, have the most stringent performance requirements, as they remain in the human body for periods ranging from 30 days to the lifetime of the patient. Only high-purity implantable grade LSR, which undergoes additional purification steps including supercritical CO2 extraction to remove all residual oligomers, is suitable for these applications.
Key specifications for implantable LSR components include:
Table 4: Performance Requirements for Implantable Grade LSR (50 Shore A)
Medical grade LSR is subject to strict regional regulatory requirements to ensure patient safety, with harmonized standards across most major markets. All medical grade LSR materials must be listed in a device’s Technical File (TF) or Design Dossier (DD) for regulatory submission, with full traceability from raw material batch to finished device.
The primary global regulatory requirements for medical grade LSR include:
For implantable devices, additional requirements include US FDA Master Access File (MAF) registration for the LSR material, allowing device manufacturers to reference the material’s safety data in their submissions without disclosing proprietary formulation details. Post-market surveillance is also required, with LSR component manufacturers required to track field performance and report any adverse events to regulatory bodies within 15 days of detection.
Medical grade LSR silicone’s unique combination of exceptional biocompatibility, thermal and chemical stability, and high-precision processability makes it an irreplaceable material for modern medical device manufacturing. Its performance advantages over traditional elastomers enable the development of safer, more reliable devices ranging from low-cost disposable sy